...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Wow…

Sep 23, 2024 10:38AM

Sep 23, 2024 11:59AM

So he is leveraging Zen to keep RVX afloat?

Share
New Message
Please login to post a reply